| An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean A Salas-Hernández, M Galleguillos, M Carrasco, A López-Cortés, ... Frontiers in Pharmacology 14, 1175737, 2023 | 13 | 2023 |
| Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis A Pérez-Villa, G Echeverría-Garcés, MJ Ramos-Medina, L Prathap, ... Scientific Reports 13 (1), 14198, 2023 | 11 | 2023 |
| Molecular pathogenesis and new therapeutic dimensions for spinal muscular atrophy A López-Cortés, G Echeverría-Garcés, MJ Ramos-Medina Biology 11 (6), 894, 2022 | 10 | 2022 |
| The close interaction between hypoxia-related proteins and metastasis in pancarcinomas A López-Cortés, L Prathap, E Ortiz-Prado, NC Kyriakidis, Á León Cáceres, ... Scientific Reports 12 (1), 11100, 2022 | 7 | 2022 |
| Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials A López-Cortés, S Guerrero, E Ortiz-Prado, V Yumiceba, A Vera-Guapi, ... Frontiers in Pharmacology 13, 833174, 2022 | 6 | 2022 |
| The pharmacoepigenetic paradigm in cancer treatment B Ocaña-Paredes, S Rivera-Orellana, D Ramírez-Sánchez, ... Frontiers in Pharmacology 15, 1381168, 2024 | 3 | 2024 |
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases MJ Ramos-Medina, G Echeverría-Garcés, NC Kyriakidis, ÁL Cáceres, ... Heliyon 10 (1), 2024 | 3 | 2024 |
| Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses A López-Cortés, A Cabrera-Andrade, G Echeverría-Garcés, ... Scientific Reports 14 (1), 19359, 2024 | 2 | 2024 |
| Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology G Echeverría-Garcés, MJ Ramos-Medina, R Vargas, A Cabrera-Andrade, ... Frontiers in Pharmacology 15, 1373007, 2024 | 2 | 2024 |
| Multi‐institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphisms C Paz‐y‐Miño, V Yumiceba, G Moreta, R Paredes, M Ruiz, L Ocampo, ... Molecular Genetics & Genomic Medicine 8 (2), e1087, 2020 | 2 | 2020 |
| Molecular analysis of ancestry informative markers (AIMs-INDELs) in a high altitude Ecuadorian mestizo population affected with breast cancer A López-Cortés, G Echeverría-Garcés, G Burgos, AK Zambrano, ... Forensic Science International: Genetics Supplement Series 6, e231-e232, 2017 | 2 | 2017 |
| Highly pathogenic avian influenza a (H5N1) clade 2.3. 4.4 b in wild birds, Ecuador A Carrazco-Montalvo, L Luje, C Rodríguez-Pólit, A Ampuño, L Patiño, ... bioRxiv, 2023.10. 18.562614, 2023 | 1 | 2023 |
| Single-nucleus lung transcriptomics and inflammatory responses in lethal COVID-19 reveal potential drugs in advanced-stage clinical trials A López-Cortés, S Guerrero, E Ortiz-Prado, V Yumiceba, A Vera-Gupi, ... | 1 | 2021 |
| Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies G Echeverría-Garcés, MJ Ramos-Medina, A González, R Vargas, ... Heliyon 10 (17), 2024 | | 2024 |
| Whole Genome Sequencing of DENV-2 isolated from Aedes aegypti mosquitoes in Esmeraldas, Ecuador. Genomic epidemiology of genotype III Southern Asian-American in the country A Carrazco-Montalvo, D Gutiérrez-Pallo, V Arévalo, P Ponce, ... bioRxiv, 2024 | | 2024 |
| Pulmonary Inflammatory Response in Lethal A López-Cortés, S Guerrero, E Ortiz-Prado, V Yumiceba, A Vera-Guapi, ... | | 2022 |
| Luis A. Quiñones, lquinone@ uchile. cl A Salas-Hernández, M Galleguillos, M Carrasco, A López-Cortés, ... | | |
